Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 April 2021 | Story Dr Nitha Ramnath | Photo Supplied
Jamba Isaac Ulengo.

Jamba Isaac Ulengo, our guest in the third episode of the Voices of the Free State podcast series is a South African rugby union player who proudly joined his team in bringing home a gold medal at the 2013 World Games. 

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series.  Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021.  Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important. The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them. 

Our podcast guest

Born in the North West town of Vryburg, Ulengo first played provincial rugby at the U16 Grant Khomo Week in 2005. While attending Jim Fouché High School in Bloemfontein, Ulengo was chosen to represent the Free State at various youth levels. As an up-and-coming player, Ulengo made his break via the FNB Varsity Cup Competition where he starred for the Shimlas, scoring 11 tries in 18 appearances over the three seasons between 2010 and 2012. A short stint with the Free State Vodacom Cup side saw him make his debut for the Blitzboks (Glasgow 2012), followed by a tournament at the London Sevens in 2014. Ulengo has been a prominent member of the South African Sevens since making his debut for the team in the Scotland leg of the 2011-2012 IRB Sevens World Series. He played in the two final tournaments of that season and then signed a two-year contract with the South African Rugby Union to represent the team in the 2012-2013 and 2013-2014 series. While he only competed at four events in his first full season, he was involved in seven of the tournaments in his second season. 

Ulengo made his return to the sport by signing a contract to play Currie Cup rugby for the Pretoria-based Blue Bulls in 2014 and for their Super Rugby franchise, the Bulls, from the 2015 Super Rugby season. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept